Sort
50,496 grants matching “lung cancer”
CCR Genomics Core
$1,245,898Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
REGULATION, RELEASE AND ACTION OF VASOPRESSIN
$1,245,652University Of Colorado Denver · P01 · FY2003 · DK
DOSE INTENSIFICATION BY GENE TRANSDUCTION IN CANCER
$1,245,485Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2000 · CA
HEALSâ¢: An Active Hydrogen Sulfide Delivery Technique for Accelerated, Effective Wound Healing
$1,244,870Reza Shekarriz · Exhalix, Llc · R44 · FY2023 · GM
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negative bacterial infections
$1,244,665David S Perlin · Rbhs-New Jersey Medical School · R01 · FY2018 · AI
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER
$1,244,611New York University School Of Medicine · U01 · FY2001 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,242,866Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
$1,242,617Geri R Donenberg · University Of Illinois At Chicago · UG3 · FY2022 · HL
PRIMARY PRODUCT/SERVICE CODE TO: B537, DESCRIPTION: CENTRAL DATA COLLECTION CENTER (CDCC), WESTAT
$1,242,264Sunitha Mathew · Westat, Inc. · N02 · FY2019 · CA
ASPiRE: Advancing Science & Practice in the Retail Environment
$1,242,249Kurt M. Ribisl · Univ Of North Carolina Chapel Hill · P01 · FY2020 · CA
Sequencing, Analysis, and Interpretation of Sequencing
$1,242,163Arul M Chinnaiyan · University Of Michigan At Ann Arbor · UM1 · FY2015 · HG
Preclinical Characterization of Drugs in Mouse Model of Lung Cancer
$1,242,074Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Washington University/Siteman Cancer Center Lead Academic Site
$1,241,704Nancy L Bartlett · Washington University · UG1 · FY2024 · CA
2/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership
$1,241,389Maria Elena Martinez · University Of California, San Diego · U54 · FY2024 · CA
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
$1,241,024William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
CREATION AND CHARACTERIZATION OF MOUSE MODELS OF HUMAN L
$1,240,360Massachusetts Institute Of Technology · U01 · FY2003 · CA
Cancer Biology and Genetics
$1,240,285Harold Varmus · National Human Genome Research Institute · ZIA · FY2013 · HG
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,240,024Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
VCU Massey Comprehensive Cancer Center NCI Community Oncology Research Program
$1,239,982Khalid Matin · Virginia Commonwealth University · UG1 · FY2025 · CA
Washington University/Siteman Cancer Center Lead Academic Site
$1,239,849Nancy L Bartlett · Washington University · UG1 · FY2025 · CA
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,239,425Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
An integrated translational approach to overcome drug resistance
$1,239,225Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2019 · CA
Preclinical drug development in pancreatic cancer
$1,238,641Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St
$1,238,550Michael Clarke · Stanford University · U54 · FY2007 · CA
DNA Vaccine for Seasonal & Pandemic Influenza
$1,238,541Deborah L. Fuller · Albany Medical College · U01 · FY2009 · AI